RESP30TB

· Thirty Respiratory Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RESP30TB, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis [Phase 2]

See pricing